BioSpace News Archive

Pure, homogenous and stable chemicals, analytical standards are responsible for precision in quantitative analysis and thus, they are used in examination of analytical method performance and calibration of apparatus.

Biophytis SA, a clinical-stage biotechnology company focused on the development of therapeutics aimed at slowing the degenerative processes associated with aging and improving functional outcomes for patients suffering from age-related diseases, including severe respiratory failure in patients suffering from COVID-19, informs its shareholders that the second combined Annual General Meeting will be held on May 10, 2021 at 5PM CET, at Sorbonne University, 4 Place Jussieu – 75005 Paris, France.

Photocure ASA, the Bladder Cancer Company, announces the publication of its sustainability report for 2020, renewing its commitment to transparency, corporate governance principles, sustainability and business ethics.

Oncopeptides AB announces that the number of shares and votes in Oncopeptides has changed due to the directed issue of 7,000,000 shares, which was carried out in March, and registered by the Swedish Companies Registration Office in April 2021.

The Illingworth Research Group, a Syneos Health® company, has been recognized with a 2021 Queen’s Award for Enterprise for International Trade.

Submission follows accelerated assessment granted by the Committee for Medicinal Products for Human Use of the European Medicines Agency of the application based on positive Phase 1b/2 CARTITUDE-1 study data

-Eagle believes new indication could allow for a significant expansion of the overall market opportunity- -RTD and Rapid Infusion (“RI”) formulations anticipated to generate approximately $25 million of combined royalty and milestone revenue at peak-

ANGLE plc (AIM: AGL OTCQX: ANPCY), a world-leading liquid biopsy company, announces that following the exercise of employee options, it has issued and allotted 203,333 new Ordinary shares of $.10 each in the Company. The New Ordinary Shares rank pari passu with the existing Ordinary shares in the Company.

- Oncolytics Biotech ® Inc. (NASDAQ: ONCY) (TSX: ONC), (the " Company ") today announced that its upcoming 2021 Annual General Meeting (the " Meeting ") will be held virtually at 12:00 p.m. Eastern Daylight Time

SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant infections, presented posters on two data sets from the Company’s Phase 3 VANISH Program demonstrating the therapeutic potential of ibrexafungerp (Brexafemme) as a treatment for vulvovaginal candidiasis (VVC